- Hall IC, O’Toole E. Intestinal flora in new-born infants with a description of a new pathogenic anaerobe, Bacillus difficilis. Am J Dis Child 1935; 49: 390–402.
- Niyogi SK, Dutta D, Bhattacharya MK, Bhattacharya SK. Frequency of isolation of toxigenic Clostridium difficile from healthy adults. Indian J Med Res 1997; 106: 497–9.
- Gorbach SL, Thadepalli H. Isolation of Clostridium in human infections: evaluation of 114 cases. J Infect Dis 1975; 131(Suppl): 81–5.
- Grasberger RC, Pietrafitta PJ. Non-spore-forming clostridial bacteremia. J Surg Oncol 1984; 25: 188–91.
- Levet PN. Time-dependent killing of Clostridium difficile by metronidazole and vancomycin. J Antimicrob Chemother 1991; 27: 55–62.
- George WL, Volpicelli NA, Stiner DB, Richman DD, Liechty EJ, Mok HYI, et al. Relapse of pseudomembranous colitis after vancomycin therapy. N Engl J Med 1979; 23: 414–5.
- Teasley DG, Gerding DN, Olson MM, Peterson LR, Gebhard RL, Schwartz MJ, et al. Prospective randomized trial of metronidazole versus vancomycin for Clostridium-difficile-associated diarrhea and colitis. Lancet 1983; 2: 1043–6.
- Kato H, Kato N, Watanabe K, Iwai N, Nakamura H, Yamamoto T, et al. Identification of toxin A-negative, toxin B-positive Clostridium difficile by PCR. J Clin Microbiol 1998; 36: 2178–82.
- Moore-Gillon JC, Eykyn S, Phillips I. Microbiology of pyogenic liver abscess. Br Med J 1981; 283: 819–21.
- McFarland LV, Mulligan ME, Kwok RY, Stamm WE. Nosocomial acquisition of Clostridium difficile infection. N Engl J Med 1989; 320: 204–9.
Scandinavian Journal of Infectious Diseases
Volume 33, 2001 - Issue 1